2.53

6.30% 0.15

Maravai Lifesciences Holdings Inc (MRVI)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt MRVI? Forum Prognose

Schlusskurs vom Vortag:

$2.38

Offen:

$2.4

24-Stunden-Volumen:

1.27M

Relative Volume:

0.70

Marktkapitalisierung:

$364.26M

Einnahmen:

$288.95M

Nettoeinkommen (Verlust:

$-119.03M

KGV:

-2.8096

EPS:

-0.9005

Netto-Cashflow:

$60.67M

1W Leistung:

-2.32%

1M Leistung:

+22.82%

6M Leistung:

-52.44%

1J Leistung:

-69.66%

1-Tages-Spanne:

$2.385

$2.57

1-Wochen-Bereich:

$2.345

$2.68

52-Wochen-Spanne:

$1.665

$10.03

Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile

Firmenname

Maravai Lifesciences Holdings Inc

Sektor

Healthcare (1161)

Branche

Biotechnology (653)

Telefon

(858) 546-0004

Adresse

10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO

Mitarbeiter

580

Twitter

Nächster Verdiensttermin

2025-03-18

Neueste SEC-Einreichungen

MRVI's Discussions on Twitter

Vergleichen Sie MRVI mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
MRVI Maravai Lifesciences Holdings Inc	2.53	372.90M	288.95M	-119.03M	60.67M	-0.9005
VRTX Vertex Pharmaceuticals Inc	470.13	119.21B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	560.93	59.16B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	325.28	40.57B	2.35B	-269.70M	-75.39M	-2.09
ARGX Argen X Se Adr	571.23	34.02B	2.58B	1.06B	-1.28B	16.33
ONC Beone Medicines Ltd Adr	295.59	29.19B	3.81B	-644.79M	-669.77M	-6.24

Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-02-26	Herabstufung	Robert W. Baird	Outperform → Neutral
2024-12-19	Eingeleitet	Guggenheim	Neutral
2024-12-05	Herabstufung	Goldman	Neutral → Sell
2024-11-14	Eingeleitet	Wolfe Research	Peer Perform
2024-11-08	Herabstufung	William Blair	Outperform → Mkt Perform
2024-08-28	Eingeleitet	Wells Fargo	Overweight
2024-08-13	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2024-04-10	Eingeleitet	Craig Hallum	Buy
2023-12-12	Hochstufung	BofA Securities	Neutral → Buy
2023-08-08	Herabstufung	KeyBanc Capital Markets	Overweight → Sector Weight
2023-05-23	Herabstufung	Credit Suisse	Outperform → Neutral
2023-05-09	Herabstufung	Goldman	Buy → Neutral
2023-01-05	Herabstufung	UBS	Buy → Neutral
2022-12-14	Eingeleitet	Deutsche Bank	Buy
2022-12-07	Eingeleitet	RBC Capital Mkts	Outperform
2022-11-03	Herabstufung	BofA Securities	Buy → Neutral
2022-08-25	Eingeleitet	Credit Suisse	Outperform
2021-08-05	Fortgesetzt	Credit Suisse	Outperform
2020-12-16	Eingeleitet	KeyBanc Capital Markets	Overweight
2020-12-15	Eingeleitet	BofA Securities	Buy
2020-12-15	Eingeleitet	Credit Suisse	Outperform
2020-12-15	Eingeleitet	Goldman	Buy
2020-12-15	Eingeleitet	Jefferies	Buy
2020-12-15	Eingeleitet	Robert W. Baird	Outperform
2020-12-15	Eingeleitet	Stifel	Buy
2020-12-15	Eingeleitet	William Blair	Outperform
2020-12-14	Eingeleitet	UBS	Buy

Alle ansehen

Maravai Lifesciences Holdings Inc Aktie (MRVI) Neueste Nachrichten

Jul 22, 2025

Is Maravai LifeSciences Holdings Inc. a good long term investmentFree Daily Trading Room Entry - Autocar Professional

Jul 22, 2025

What drives Maravai LifeSciences Holdings Inc. stock priceFree Stock Market Forecast Reports - jammulinksnews.com

Jul 22, 2025

Maravai LifeSciences Holdings Inc. Stock Analysis and ForecastMarket-leading growth rates - jammulinksnews.com

Jul 22, 2025

MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire

Jul 22, 2025

MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.

Jul 22, 2025

What analysts say about Maravai LifeSciences Holdings Inc. stockExceptional trading results - jammulinksnews.com

Jul 22, 2025

16,587 Shares in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Purchased by Teacher Retirement System of Texas - Defense World

Jul 22, 2025

Jul 18, 2025

Maravai LifeSciences appoints Deloitte as new auditor, replaces EY - Investing.com Australia

Jul 18, 2025

Maravai LifeSciences appoints Deloitte as new auditor, replaces EY By Investing.com - Investing.com India

Jul 18, 2025

Maravai LifeSciences (MRVI) Undergoes Leadership Overhaul Amid Transition - MSN

Jul 18, 2025

Johnson Fistel, PLLP Continues Investigation Claims on Behalf of Quantum Computing Inc. (QUBT), AppLovin Corporation (APP), Skyworks Solutions, Inc. (SWKS), and Maravai LifeSciences Holdings, Inc. (MRVI) Long-Term Shareholders - GlobeNewswire

Jul 18, 2025

Jul 15, 2025

Why Maravai LifeSciences Holdings Inc. stock attracts strong analyst attention5x Profit Potential - beatles.ru

Jul 15, 2025

What makes Maravai LifeSciences Holdings Inc. stock price move sharplyHigh Potential Safe Trades - Newser

Jul 15, 2025

How Maravai LifeSciences Holdings Inc. stock performs during market volatilityProtected Capital Trading Plan - Newser

Jul 15, 2025

Jul 14, 2025

MARAVAI ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire

Jul 14, 2025

Jul 13, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Reach Out - ACCESS Newswire

Jul 13, 2025

Jul 12, 2025

Here's Why Maravai LifeSciences Holdings (NASDAQ:MRVI) Can Afford Some Debt - 富途牛牛

Jul 12, 2025

Jul 11, 2025

MARAVAI LIFESCIENCES INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maravai LifeSciences Holdings, Inc.MRVI - PR Newswire

Jul 11, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

Jul 11, 2025

Jul 10, 2025

Traders Purchase High Volume of Put Options on Maravai LifeSciences (NASDAQ:MRVI) - Defense World

Jul 10, 2025

Jul 09, 2025